NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. ("Petros" or "the Company") (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today provides positive ...
NEW YORK, Jan. 18, 2022 /PRNewswire/ -- Petros Pharmaceuticals, Inc. ("Petros" or "the Company") (Nasdaq: PTPI), a leading provider of therapeutics for men's health, has initiated two self-selection ...
CAMPBELL, CA / ACCESSWIRE / March 14, 2019 / VIVUS, Inc. (NASDAQ: VVUS; the "Company"), a biopharmaceutical company, today announced that the Ministry of Health of the Russian Federation has approved ...
NEW YORK, NY / ACCESSWIRE / December 12, 2023 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI), a company focused on expanding consumer access to medication through over-the- counter (OTC) drug ...
TORONTO--(BUSINESS WIRE)--Acerus Pharmaceuticals Corporation (TSX:ASP) (“Acerus” or the “Company”) today announced that it has filed a New Drug Submission (“NDS”) for Avanafil with Health Canada.
Choosing the right erectile dysfunction medication can feel overwhelming for many people who are trying to understand how ED drugs differ in effectiveness, timing, side effects, and cost. With several ...
A multicenter phase III trial of avanafil in 200 Korean men with erectile dysfunction has shown a significant improvement in patient erectile function at doses of 100 or 200 mg. During the 12-week ...
Sexual Dysfunction in Men With Spinal Cord Injury How do spinal cord injuries affect male sexual function? This study takes a look at the neurological pathways involved. International Journal of ...
TORONTO--(BUSINESS WIRE)--Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) (“Acerus” or the “Company”) today announced that Health Canada has completed the initial screening process for the ...
Erectile dysfunction drugs were associated with reduced risk of Alzheimer's disease, electronic health record (EHR) data from 270,000 men in the U.K. suggested. Over a median follow-up of about 5 ...
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. VIVUS, Inc. (NASDAQ: VVUS; the "Company"), a biopharmaceutical company, today announced that the Ministry of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results